KKR has led a $75 million series B funding round in Digital Diagnostics, a specialist in AI healthcare diagnosis. Investors including Cedar Pine, Kinderhook, 8VC, Optum Ventures, OSF Ventures and the University of Iowa also took part in the round.
The latest funding has almost doubled the company’s total outside capital raised to $130 million.
In January, KKR closed its Health Care Strategic Growth Fund II on $4 billion, almost three-times bigger that it’s previous healthcare fund which closed with $1.45bn in capital commitments.
21 Invest Mulls Sale of $500M Eye-Care Firm Sifi - IntroductionIn a move that could reshape the eye-care industry, Italian private equity firm 21 Invest is reportedly considering the sale of Sifi,...
AbbVie's Transformative Acquisition of Cerevel Therapeutics
AbbVie's $8.7 billion acquisition of Cerevel Therapeutics is set to reshape the neuroscience landscape, unlocking innovative therapies and...
Rite Aid's Elixir Buyer Must Pay Additional $50M in Ch. 11 Sale
In a pivotal move for its bankruptcy restructuring, embattled pharmacy chain Rite Aid has secured an additional $50 million from...
Pieris Pharma Stock Surges on Palvella Therapeutics Merger Deal
Pieris Pharmaceuticals (PIRS) saw its stock soar by over 70% on July 24, 2024, following the announcement of an all-stock merger deal...